Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 729 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
TODD STRATEGY GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q2
TODD STRATEGY GROUP for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q2
TODD STRATEGY GROUP for MILLIPORESIGMA
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Pharmacy
View →
Q2
TODD STRATEGY GROUP for GENENTECH, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q2
TODD STRATEGY GROUP for EMD SERONO INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy, Health Issues
View →
Q2
ALNYLAM PHARMACEUTICALS, INC. for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate
Pharmacy, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q2
SHIONOGI INC. for SHIONOGI INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Insurance, Medicare/Medicaid
View →
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $40,000.00 income
Manufacturing, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
Q2
FORBES-TATE for INDEPENDENT PHARMACY COOPERATIVE
2nd Quarter (Apr 1 - June 30) 2026 · Wisconsin · House · Senate · $40,000.00 income
Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations
View →
Q2
K&L GATES, LLP for BORYUNG CORPORATION
2nd Quarter (Apr 1 - June 30) 2026
Aerospace, Pharmacy, Science/Technology
View →
Q2
BIOGEN for BIOGEN
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
ISEMAN & ASSOCIATES LLC for TICHENOR VENTURES, LLC
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate
Medical/Disease Research/Clinical Labs, Pharmacy, Aviation/Airlines/Airports, Budget/Appropriations
View →
Q2
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q2
TODD STRATEGY GROUP for ASTELLAS PHARMA US, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $50,000.00 income
Health Issues, Pharmacy
View →
Q2
JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Pharmacy
View →
Q2
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues
View →
Q2
VANDERBILT UNIVERSITY MEDICAL CENTER for VANDERBILT UNIVERSITY MEDICAL CENTER
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate
Immigration, Veterans, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q2
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Copyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign)
View →
Q2
DLA PIPER LLP (US) for BIOGEN, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
ALSTON & BIRD LLP for BIOMERIEUX, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Utah · House · Senate · $70,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Defense, Housing, Health Issues, Medicare/Medicaid
View →
Previous Page 2 of 30 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem